IVDs (in vitro diagnostics) to be covered in EU vigilance document:
This article was originally published in Clinica
The European Commission's medical device expert group meeting has determined that products covered by the In Vitro Diagnostics Directive should be included in the Commission's vigilance guidance document. Representatives from the Commission, member states and industry decided at their meeting last month that these products should be covered in a new appendix to the document, where the concept of indirect harm would also be addressed.
You may also be interested in...
Financial ties between companies and healthcare bodies distort the production and use of evidence, claims a paper co-authored by researchers, clinicians and decision makers, including a representative of Germany’s HTA body, IQWiG.
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.